Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
作者信息
TOOHEY M
出版信息
Br Med J. 1952 Sep 27;2(4786):687-90. doi: 10.1136/bmj.2.4786.687.
Abstract
摘要
相似文献
1
Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.维生素K对抗抗凝剂双香豆素、曲美香豆素和苯茚二酮的作用。
Br Med J. 1952 Sep 27;2(4786):687-90. doi: 10.1136/bmj.2.4786.687.
2
Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.维生素K制剂对双香豆素和曲美香豆素所致低凝血酶原血症的作用。
Br Med J. 1952 Feb 23;1(4755):412-5. doi: 10.1136/bmj.1.4755.412.
3
Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.口服维生素K1对双香豆乙酯和苯茚二酮作用的拮抗效应。
Br Med J. 1954 Oct 23;2(4894):956-9. doi: 10.1136/bmj.2.4894.956.
4
[Progress in management of dicumarol therapy; simplification of control; vitamin KI as antidote].[双香豆素治疗的管理进展；控制方法的简化；维生素 KI 作为解毒剂]
Helv Med Acta. 1952 Oct;19(4-5):411-6.
5
Vitamin K1 in treatment of bishydroxycoumarin-induced hypoprothrombinemia; comparison of intravenous and intramuscular administration.维生素K1治疗双香豆素诱导的低凝血酶原血症；静脉注射与肌肉注射的比较
J Am Med Assoc. 1956 Jul 21;161(12):1145-7. doi: 10.1001/jama.1956.02970120027008.
6
7
The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan.静脉注射乳化维生素K1对氨甲环酸所致低凝血酶原血症的影响。
N Engl J Med. 1953 Jan 8;248(2):57-8. doi: 10.1056/NEJM195301082480204.
8
[Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].[香豆素衍生物（双香豆素和曲美香豆素）对抗凝治疗的控制]
Sem Med. 1952 Mar 10;28(10):199-203.
9
The comparative effects of menadione sodium bisulfite and vitamin K1 on the hypoprothrombinemia induced by dicumarol.亚硫酸氢钠甲萘醌和维生素K1对双香豆素所致低凝血酶原血症的比较效应。
J Lab Clin Med. 1953 Mar;41(3):393-404.
10
Studies on disturbution of dicumarol.
Proc Soc Exp Biol Med. 1956 Jun;92(2):449-51. doi: 10.3181/00379727-92-22506.
引用本文的文献
1
Effect of intravenous vitamin K1 on the action of phenindione.静脉注射维生素K1对苯茚二酮作用的影响。
Br Med J. 1955 Dec 10;2(4953):1427-9. doi: 10.1136/bmj.2.4953.1427.
2
Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.维生素K1在苯茚二酮诱导的抗凝治疗中的应用
Can Med Assoc J. 1955 Feb 1;72(3):184-5.
3
Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.口服维生素K1对双香豆乙酯和苯茚二酮作用的拮抗效应。
Br Med J. 1954 Oct 23;2(4894):956-9. doi: 10.1136/bmj.2.4894.956.
4
Vitamin K in anticoagulant therapy.抗凝治疗中的维生素K。
Br Med J. 1954 May 1;1(4869):1020-2. doi: 10.1136/bmj.1.4869.1020.
5
[Clinical studies on blood coagulation factors, prothrombin, factor V and factor VII liver diseases and their response to vitamin K1 and synka-vit].关于凝血因子、凝血酶原、因子V和因子VII在肝脏疾病中的临床研究及其对维生素K1和合成维生素K的反应
Klin Wochenschr. 1953 Sep 1;31(33-34):781-7. doi: 10.1007/BF01472658.
6
Clinical trial of phenylindanedione as an anticoagulant.作为抗凝剂的苯茚二酮的临床试验。
Br Med J. 1953 Mar 21;1(4811):650-2. doi: 10.1136/bmj.1.4811.650.
本文引用的文献
1
Antagonism of dicumarol by vitamin K preparations.维生素K制剂对双香豆醇的拮抗作用。
N Engl J Med. 1950 Feb 9;242(6):211-5. doi: 10.1056/NEJM195002092420604.
2
3
Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.合成水溶性维生素K制剂在双香豆素诱导的低凝血酶原血症中的有效性。
J Am Med Assoc. 1951 Feb 10;145(6):393-9. doi: 10.1001/jama.1951.02920240029008.
Zotero 插件